EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis

Akihisa Adachi iD, Itaru Naitoh iD, Michihiro Yoshida iD, Yasuki Hori iD, Akihisa Kato iD, Kenta Kachi, Tadashi Toyohara iD, Kayoko Oda, Yusuke Kito, Kenji Urakabe iD, Toshitaka Mori, Hiromi Kataoka

JGH Open · 2026-07 · 10 (7)

DOI: 10.1002/jgh3.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JGH Open, online erschienen am 20.07.2026. Verfasst von Akihisa Adachi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Despite the recommendation of steroid therapy for type 1 autoimmune pancreatitis (AIP), the value of steroid pulse therapy remains unclear. This study aimed to assess the efficacy and safety of steroid pulse therapy in patients with AIP. Methods and Results Of 121 patients with type 1 AIP who were identified, 116 with adequate follow‐up data were included in the analysis. Patients were classified into four groups according to the initial treatment modality—pulse therapy alone (Pulse alone group), pulse therapy followed by oral steroid therapy (Pulse + PSL group), conventional oral steroid therapy (PSL group), and observation without treatment (Observation group)—and short‐ and long‐term clinical response, relapse rates, and steroid‐associated adverse events were compared across these groups. The numbers of patients in the Pulse alone, Pulse + PSL, PSL, and Observation groups were 12, 13, 68, and 23, respectively. After 2 weeks of steroid initiation, steroid pulse groups (Pulse alone and Pulse + PSL group) showed a significantly greater reduction in serum IgG4 levels than the PSL group ( p = 0.048). Pulse + PSL was associated with a significantly lower relapse rate than PSL (log‐rank test p = 0.02; multivariate Cox regression p = 0.048), with no differences in adverse events. Rates of relapse and adverse events did not differ significantly between the Pulse alone and Observation groups.

Conclusions

Steroid pulse therapy may serve as a useful therapeutic option when conducting a steroid trial and may help reduce relapse rate in the management of type 1 AIP.

Schlagwörter

Stichwörter der Autor:innen

adverse eventautoimmune pancreatitisrelapsesteroid pulse

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan.
  • Department of Gastroenterology Nagoya City University Midori Municipal Hospital Nagoya Japan.

ORCID-Profile: Akihisa Adachi, Itaru Naitoh, Michihiro Yoshida, Yasuki Hori, Akihisa Kato, Tadashi Toyohara, Kenji Urakabe

Zitieren

APA

Adachi, A., Naitoh, I., Yoshida, M., Hori, Y., Kato, A., Kachi, K., Toyohara, T., Oda, K., Kito, Y., Urakabe, K., Mori, T., & Kataoka, H. (2026). Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis. JGH Open, 10(7). https://doi.org/10.1002/jgh3.70448

Vancouver

Adachi A, Naitoh I, Yoshida M, Hori Y, Kato A, Kachi K, et al. Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis. JGH Open. 2026;10(7). doi:10.1002/jgh3.70448

BibTeX
@article{Adachi2026,
  author = {Adachi, Akihisa and Naitoh, Itaru and Yoshida, Michihiro and Hori, Yasuki and Kato, Akihisa and Kachi, Kenta and Toyohara, Tadashi and Oda, Kayoko and Kito, Yusuke and Urakabe, Kenji and Mori, Toshitaka and Kataoka, Hiromi},
  title = {Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis},
  journal = {JGH Open},
  year = {2026},
  volume = {10},
  number = {7},
  doi = {10.1002/jgh3.70448}
}
Kostenlos starten →